LuCaBIS: A Burden of Illness Study in Stage IB-IIIA NSCLC Patients
Research type
Research Study
Full title
LuCaBIS: A Burden of Illness Study in Patients with Stage IB-IIIA Non–small Cell Lung Cancer (NSCLC)
IRAS ID
117859
Contact name
Penella J Woll
Contact email
Sponsor organisation
GlaxoSmithKline (GSK)
REC name
Yorkshire & The Humber - Sheffield Research Ethics Committee
REC reference
12/YH/0542
Date of REC Opinion
23 Jan 2013
REC opinion
Further Information Favourable Opinion